Roger Bendelac
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Roger Bendelac
Roger Bendelac is recorded as CEO at Drugs Made In America Acquisition Corp. (DMAA). Drugs Made In America Acquisition Corp. reported in an 8-K filed March 6, 2026 that Roger Bendelac was appointed Chief Executive Officer, effective February 28, 2026.
“On February 28, 2026, Roger Bendelac was appointed to the position of Chief Executive Officer of the Company to be effective as of the date of Ms. Stockwell's resignation as the Company's Chief Executive Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-02-28–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Drugs Made In America Acquisition Corp.
Other people whose current roles at this company are on record from its filings.
- Saleem Elmasri CFO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.